ES2572377T3 - Método para la detección de la presencia, o el riesgo, de cáncer de vejiga - Google Patents
Método para la detección de la presencia, o el riesgo, de cáncer de vejigaInfo
- Publication number
- ES2572377T3 ES2572377T3 ES10737623T ES10737623T ES2572377T3 ES 2572377 T3 ES2572377 T3 ES 2572377T3 ES 10737623 T ES10737623 T ES 10737623T ES 10737623 T ES10737623 T ES 10737623T ES 2572377 T3 ES2572377 T3 ES 2572377T3
- Authority
- ES
- Spain
- Prior art keywords
- cea
- vegf
- detecting
- nse
- risk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Un método para detectar la presencia o el riesgo de cáncer de vejiga en un paciente, que comprende detectar la presencia de CEA en una muestra de suero aislada del paciente y detectar la presencia de uno o más biomarcadores seleccionados de VEGF, IL-8, NGAL, NSE, EGF, TM, Dímero D, MMP-9, IL-6, FAS, TUP y NMP22 en una muestra de orina aislada del paciente, en el que la presencia de una combinación de CEA en la muestra de suero y uno o más biomarcadores en la muestra de orina indica la presencia o el riesgo de cáncer de vejiga, en el que la combinación de CEA y al menos otro biomarcador se selecciona de: VEGF, CEA y TUP; VEGF, CEA, MMP-9 e IL-6; VEGF, CEA, TM, NSE y Dímero D; VEGF, CEA, NSE, TM e IL-8; CEA, IL-8 y NGAL; CEA, IL-8, NGAL, NSE y VEGF; NMP-22 y CEA; FAS, EGF, NSE, NMP-22 y CEA; o CEA y VEGF.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0913249A GB0913249D0 (en) | 2009-07-29 | 2009-07-29 | Bladder cancer |
GB0916193A GB0916193D0 (en) | 2009-09-15 | 2009-09-15 | Bladder cancer |
PCT/GB2010/051255 WO2011012901A1 (en) | 2009-07-29 | 2010-07-29 | Method for detection of, or the risk of, bladder cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2572377T3 true ES2572377T3 (es) | 2016-05-31 |
Family
ID=42710807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES10737623T Active ES2572377T3 (es) | 2009-07-29 | 2010-07-29 | Método para la detección de la presencia, o el riesgo, de cáncer de vejiga |
Country Status (5)
Country | Link |
---|---|
US (1) | US9562905B2 (es) |
EP (1) | EP2460012B1 (es) |
CN (1) | CN102625914B (es) |
ES (1) | ES2572377T3 (es) |
WO (1) | WO2011012901A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9249467B2 (en) * | 2011-09-16 | 2016-02-02 | Steven Goodison | Bladder cancer detection composition, kit and associated methods |
GB201218570D0 (en) | 2012-10-16 | 2012-11-28 | Randox Lab Ltd | Method |
CN105683759B (zh) * | 2013-08-07 | 2019-03-29 | 瑞颂医药公司 | 非典型溶血性尿毒综合征(aHUS)生物标志物蛋白 |
WO2015150834A1 (en) * | 2014-04-04 | 2015-10-08 | Randox Laboratories Ltd. | Diagnosis of urothelial cancer |
KR101638321B1 (ko) | 2014-07-24 | 2016-07-12 | 에스엘 주식회사 | 차량용 헤드 램프 |
KR20160012547A (ko) | 2014-07-24 | 2016-02-03 | 에스엘 주식회사 | 차량용 헤드 램프 |
KR20160012550A (ko) | 2014-07-24 | 2016-02-03 | 에스엘 주식회사 | 차량용 헤드 램프 |
GB201501597D0 (en) * | 2015-01-30 | 2015-03-18 | Randox Lab Ltd | Thrombomodulin |
CN105232060A (zh) * | 2015-08-31 | 2016-01-13 | 陈琼 | 基于独立风险因子组合筛查的预警系统 |
WO2018092205A1 (ja) * | 2016-11-16 | 2018-05-24 | 株式会社アシックス | 靴 |
CN106680512B (zh) * | 2017-01-23 | 2017-12-12 | 广州华弘生物科技有限公司 | 一种核基质蛋白22的快速检测试剂盒及其应用 |
GB201818744D0 (en) * | 2018-11-16 | 2019-01-02 | Randox Laboratories Ltd | Detection of bladder cancer |
KR102235718B1 (ko) * | 2019-08-01 | 2021-04-05 | 한국전자기술연구원 | 방광암 진단 또는 예후 분석용 바이오마커 조성물, 키트 및 이를 이용한 진단 방법 |
BR112022003869A2 (pt) * | 2019-09-05 | 2022-05-24 | Univ California | Método não invasivo para quantificar função renal e declínio funcional |
RU2741690C1 (ru) * | 2020-06-08 | 2021-01-28 | федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии" Министерства здравоохранения Российской Федерации | Способ прогнозирования течения низкодифференцированных глиальных опухолей на основе цитокинового микроокружения |
US20230400466A1 (en) * | 2022-05-25 | 2023-12-14 | University Of Houston System | Methods and systems for risk stratification and management of bladder cancer |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ297165B6 (cs) | 1997-04-21 | 2006-09-13 | Randox Laboratories Ltd. A British Company Of Ardmore | Zpusob výroby zarízení s pevnou fází k provádení multianalytních rozboru |
EP1477803A1 (en) | 2003-05-15 | 2004-11-17 | Europroteome AG | Serum protein profiling for the diagnosis of epithelial cancers |
ITPD20030264A1 (it) * | 2003-10-30 | 2005-04-30 | Xeptagen Spa | Metodo di diagnosi altamente specifico per neoplasie |
BRPI0617488A2 (pt) * | 2005-10-21 | 2011-07-26 | Bayer Healthcare Llc | mÉtodo para a monitoraÇço do estado de uma doenÇa associada a uma via de vegf-165 ativada por ultra-expressço ou por mutaÇço de proteÍna vegf-165 em um paciente, mÉtodo de seleÇço de terapia para um paciente humano com uma doenÇa e mÉtodo de dignàstico para detectar uma doenÇa associada a uma via de vegf-165 ativada por ultra-expressço ou por mutaÇço de proteÍna vegf-165 em um paciente |
WO2009017475A1 (en) | 2007-07-27 | 2009-02-05 | Children's Medical Center Corporation | Methods for diagnosis and prognosis of epithelial cancers |
US20120231963A1 (en) | 2011-03-10 | 2012-09-13 | Raybiotech, Inc, | Biotin-label-based antibody array for high-content profiling of protein expression |
-
2010
- 2010-07-29 CN CN201080033545.2A patent/CN102625914B/zh not_active Expired - Fee Related
- 2010-07-29 ES ES10737623T patent/ES2572377T3/es active Active
- 2010-07-29 EP EP10737623.8A patent/EP2460012B1/en active Active
- 2010-07-29 US US13/386,228 patent/US9562905B2/en active Active
- 2010-07-29 WO PCT/GB2010/051255 patent/WO2011012901A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20120135886A1 (en) | 2012-05-31 |
WO2011012901A1 (en) | 2011-02-03 |
EP2460012B1 (en) | 2016-04-20 |
EP2460012A1 (en) | 2012-06-06 |
CN102625914A (zh) | 2012-08-01 |
US9562905B2 (en) | 2017-02-07 |
CN102625914B (zh) | 2017-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2572377T3 (es) | Método para la detección de la presencia, o el riesgo, de cáncer de vejiga | |
NZ593514A (en) | p-mTOR and p-AKT as Ratio Based Biomarkers for the Prognosis and/or Diagnosis of Cancer | |
DE602006018578D1 (de) | Diagnose- und prognoseverfahren von blasenkrebs. | |
AR057153A1 (es) | Metodo in vitro no invasivo para detectar carcinoma transicional de vejiga | |
BRPI0720371B8 (pt) | métodos para diagnóstico ou monitoramento da progressão de câncer de próstata em um indivíduo e uso in vitro de pelo menos um homeodomínio contendo o fator de transcrição como um biomarcador para câncer de próstata | |
ATE501267T1 (de) | Apolipoprotein-a-ii-isoform als biomarker für prostatakrebs | |
GB2467704A (en) | Methods of monitoring conditions by sequence analysis | |
WO2008134526A3 (en) | Glycoprotein profiling of bladder cancer | |
WO2009024691A3 (fr) | Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal | |
MX2018011725A (es) | Metodo para emplear expresion genica para determinar pronostico de cancer de prostata. | |
WO2011072177A3 (en) | Biomarker assay for diagnosis and classification of cardiovascular disease | |
BR112013000869A2 (pt) | método para diagnóstico de câncer de próstata (pca) com uma sensibilidade desejada em um sujeito; método para monitorar a progressão do câncer de próstata (pca) em um sujeito; método para avaliar se um sujeito tem que ser submetido a uma biópsia de próstata; kit compreendendo um primeiro componente e, opcionalmente, um segundo componente e uso de um kit | |
BRPI1007443A2 (pt) | biomarcadores séricos e de urina associados à nefropatia diabética | |
DK2211180T3 (da) | Anvendelse af protein SATB2 som markør til at skelne colorectal cancer fra andre former for cancer | |
WO2010099137A3 (en) | In situ methods for monitoring the emt status of tumor cells in vivo | |
PE20120592A1 (es) | Metodo con biomarcadores para el seguimiento de un tratamiento | |
BR112014031958A2 (pt) | bag3 como marcador de tecido e soro bioquímico | |
BR112018067990A2 (pt) | cromogranina a como um marcador para câncer de bexiga | |
BR112018072498A2 (pt) | marcadores de câncer do endométrio | |
PE20120793A1 (es) | Bioensayo de control de calidad para productos nutriceuticos y medicinales | |
ES2493069T3 (es) | CYBP como marcador del cáncer de pulmón | |
ES2530574T3 (es) | Biomarcadores asociados a la nefropatía | |
ES2530866T3 (es) | Marcador temprano de proteinuria en pacientes tratados con un tratamiento anti-VEGF | |
BR112012023485A2 (pt) | marcadores moleculares para infecções do trato urinário. | |
Lumachi et al. | Serum tumor markers carcinoma antigen (CA) 72− 4 versus carcinoembryonic antigen (CEA) in patients with early stage (IA− IB) gastric cancer |